Preparation of IL-2 Batches.
To produce LBRM-33 cell-derived IL-2, LBRM cells were grown in culture medium (a 50% vot/vol mixture of Click's and RPMI 1640 media supplemented with 10 mM Hepes, fresh glutamine, 5 × 10 -5 M 2-mercaptoethanol, and 5% fetal calf serum (FCS)) and were washed and replated in serum-free medium containing 1% phytohemagglutinin (PHA-M) (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) for 6 h. After exchanging PHA-containing medium with normal medium, the cells were incubated for an additional 24 h, and the supernatant was recovered. EI_~-derived IL-2 was produced by seeding cells in serum-free medium (density of 1 × 10S/ml) and stimulating for 36 h with 10 ng/ml phorbyl myristic acetate (Sigma Inc., Munich, Federal Republic of Germany [FRG] ). IL-2 from CBA mouse spleen cells (107 eells/ml) was produced under serum-free conditions by stimulating with 1 btg/ml Con A (Pharmaeia Fine Chemicals, Uppsala, Sweden) for 24 h as described previously (6) . The supernatants were harvested and are termed "crude supernatant."
Semipurification oflL-2. The various culture supernatants were concentrated by ultrafiltration with an Amicon YM-10 membrane (Amicon Corp., Scientific Sys. Div., Lexington, MA) and subjected to fractionated (NH4)2SO4 precipitation. Proteins precipitating between 40 and 80% (NH4)2SO4 saturation were dialyzed against 0.02 M phosphate-buffered saline (PBS) (pH 7.4), concentrated, and applied to a previously calibrated Sephadex G-100 column. Effluent fractions were tested for IL-2 activity.
Assay for IL-2 Activity. IL-2 was assayed by its ability to sustain in vitro growth of C1-3 cells, 
Polyclonal Activation of CTL-P.
Replicates of Lyt-l-2,3 + T responder cells (106) were seeded into flat-bottomed 96-wetl microplates in 200 #1 medium containing 2.5/zg Con A/ml plus the lymphokine batch indicated. The proliferative response was assayed by pulsing cultures after 42 h for 6 h with 0.5/zCi aH [TdR] . The polyclonal induction of CTL was measured in a lectinmediated universal readout (15) , and cells of four microeultures were pooled, washed once, and resuspended in 1 ml. Graded numbers of viable cells were incubated with a constant number (2 × 106) SlCr-labeled P815 tumor cells in the presence of 10/xg/ml PHA-P (Gibco Laboratories). Percent specific lysis was calculated as detailed previously (6) .
Preparation of Macrophage Culture Supernatant Rich in IL-I.
Thioglyeolate-induced peritoneal macrophages (4 × 10/ml) were plated in 2 ml culture medium containing 0.5% FCS and incubated with 5/.tg/ml lipopolysaccharide (Difco Laboratories, Detroit, Michigan) for 24 h. The culture supernatants were harvested and dialyzed against culture medium. These supernatants, which lacked detectable IL-2 activity, were rich in IL-1 activity as assayed by their ability to replace macrophages required for the Con A-induced production of IL-2 from purified T cells (9) . The activity of IL-1 was compared with a standard preparation arbitrarily set as 100 U/ml (16) . The IL-1 preparation used contained 250 U.
Results and Discussion
To evaluate our notion that IL-2 alone is not sufficient to cause the differentiation of primary CTL in vitro, our experimental protocol included the following rationale. First, it was essential to avoid interference by regulatory Lyt-1 + T ceils during CTL induction because such cells would provide IL-2 as well as other putative helper factors endogeneously. To this end, negatively selected, macrophage-depleted Lyt-2 + cells were used as the responder population. Second, we needed to produce a source of factor that retained differentiation activity but lacked demonstrable IL-2. This was achieved using an IL-2-addicted cell line to absorb out IL-2 from crude Con Aactivated supernatants. As shown in Fig. 1 (right panel) , absorption of Con A supernatants five times with CI-3 cells completely removed IL-2, as measured by its ability to cause proliferation of C1-3 cells. That this factor still had CTDF activity is described subsequently. Four sources of IL-2 were investigated for their ability to cause proliferation of Lyt-2 + T cells as well their differentiation into CTL. As shown in Fig. 1 (left panel) , the four factors EL4, LBRM, crude Con A supernatant, and semipurified Con A supernatant exhibited comparable IL-2 activity, as measured by their ability to cause proliferation of the IL-2-addicted cell line C1-3. In addition, as shown in Table I , all factors caused Con A preactivated Lyt-2 + T cells to proliferate to a similar extent. However, in contrast to their comparable proliferation activities (i.e., IL-2), it was only the crude Con A supernatant that caused the induction of high levels of cytolytic activity (Fig. 2 A) . These data indicate that IL-2-driven proliferation (growth) of preactivated Lyt-2 + cells does not necessarily result in CTL generation. Furthermore, they infer that a second activity present in crude supernatants causes proliferating CTL-P to differentiate into CTL.
Further evidence for this notion was obtained in experiments in which Con A supernatants depleted of IL-2 by absorption with clone 3 cells and lacking proliferation activity (Fig. 1 B) were shown able to cause CTL induction (Fig. 2 A, B, C) . However, far more striking was the observation that the IL-2-depleted Con A supernatant could restore the CTL-inducing activity of those sources of IL-2 that alone caused only Con A-preactivated CTL-P to proliferate (Fig. 2 A, B, C) . In these combination experiments strong cytolytic responses were induced.
Taken together our results lead us to conclude that the role of IL-2 in CTL induction is to cause the clonal expansion of those CTL-P that have been preactivated by antigen or mitogen. However, such proliferating CTL-P do not differentiate into cytolytic effector cells. For this to occur, they must be stimulated by a second factor, distinct from IL-2, termed here CTDF. Although our data implicate the Lyt-2 + cell as the cell that responds to CTDF, at this stage we can only speculate as to the nafure of the cell that produces the factor. Presumably it is not the Lyt-2 + cell itself, since such cells, driven to proliferate by IL-2, fail to differentiate into CTL. The data depicted in Fig. 2 C also argue against the macrophage as the producer cell, because the supernatants of activated macrophage were devoid of CTDF activity. Because these supernatants were rich in IL-1, these data also serve to indicate that IL-t is not the differentiation factor. Clearly further investigations are necessary to define the origin of CTDF and its relationship to other known lymphokines (17, 18) . We do not favor the idea that CTDF is identical to )' interferon (IF), because Lyt-2 ÷ cytotoxic T cells themselves produce ),-IF and should therefore be expected to provide the differentiation signal endogenously (19) . Biochemical and functional investigations are required before a clearer picture will emerge.
The dissection of proliferative and differentiative signals controlling cytolytic responses of CTL-P in a lectin-mediated universal readout resembles that recently observed for IgM responses in unprimed B cells (20, 21) . Could it be that the rules governing growth and differentiation of effector cells of both the T cell and B cell lineage parallel each other? Summary Evidence is presented that interleukin 2 (IL-2) is not sufficient to cause the differentiation of primary cytotoxic T lymphocytes (CTL). Sources of IL-2 were compared for their ability to cause proliferation as well as differentiation into CTL, Whereas all factors caused proliferation, only the crude Con A supernatant had cytotoxic T cell differentiation factor (CTDF) activity. Furthermore, factors abmorbed with an IL-2-dependent cell line to remove IL-2 still retained CTDF activity, Thus~ IL-2 functions to cause clonal expansion of CTL precursors preaetivated by antigen or mitogen, but for their differentiation into CTL, an additional factor is required, here called CTDF.
